Orchard Therapeutics
Gene therapy company developing treatments for rare inherited diseases.
About
Orchard Therapeutics is a gene therapy company focused on developing and commercializing HSC gene therapy for severe and other genetic diseases. They aim to transform the lives of people living with these conditions, building on decades of research to apply their platform to areas of significant medical need. The company shares stories and experiences of families impacted by diseases like metachromatic leukodystrophy to motivate their mission.
Key facts
At-a-glance profile data
- Website
- orchard-tx.com
- Headquarters
- Boston, United States
- Founded
- 2015
- Employees
- 248
- Total funding
- $125M (IPO)
- Business model
- B2B
- Tags
- BiotechMedTechHealthTechGenomicsDrug Discovery
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Feb 2019 | IPO | $125M | - |
Tech stack
Detected on orchard-tx.com, last scanned 25 Sept 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Tag Manager
- SEO
- Yoast SEO
- Support
- Freshdesk
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Microsoft 365
- Video / media
- Vimeo
Frequently asked
How much funding has Orchard Therapeutics raised?
Orchard Therapeutics has raised a total of $125M in funding. The most recent round on record is IPO.
How many employees does Orchard Therapeutics have?
Orchard Therapeutics has approximately 248 people on record.